SCLAVO BIOCINE SPA has a total of 17 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are CSL Behring Lengnau AG, OPKO BIOLOGICS LTD and THROMBOSIS RES INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Canada | 1 | |
#5 | Japan | 1 | |
#6 | Mexico | 1 | |
#7 | Saudi Arabia | 1 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Rappuoli Rino | 10 |
#2 | Hol Wim | 5 |
#3 | Pizza Mariagrazia | 4 |
#4 | Bugnoli Massimo | 4 |
#5 | Domenighini Mario | 4 |
#6 | Ghiara Paolo | 3 |
#7 | Villa Luigi | 3 |
#8 | Norelli Francesco | 2 |
#9 | Viti Stefano | 2 |
#10 | Papini Emanuele | 2 |
Publication | Filing date | Title |
---|---|---|
AU3751093A | Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine | |
AU3746293A | Conjugates formed from heat shock proteins and oligo- or polysaccharides | |
WO9318150A1 | Helicobacter pylori proteins useful for vaccines and diagnostics | |
CA2070903A1 | Process for purifying hepatitis a virus (hav), virus thus purified and vaccine compositions containing it |